Moderna is trading at $200.31, up 4.02% on October 1, 2026; no clear company-specific announcement explaining the gain appeared in available search results.

  • September 30 company news announced Juan Andres’s appointment as chief operating officer, effective October 5; timing alone does not establish a link to the gain.
  • Broader markets were slightly lower, offering no clear explanation in the supplied context.
  • A September 30 report said Citigroup downgraded the stock to Sell while raising its price target; that earlier news does not establish the rebound’s cause.